BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 24175300)

  • 1. JIS definition identified more Malaysian adults with metabolic syndrome compared to the NCEP-ATP III and IDF criteria.
    Ramli AS; Daher AM; Nor-Ashikin MN; Mat-Nasir N; Ng KK; Miskan M; Ambigga KS; Ariffin F; Mazapuspavina MY; Abdul-Razak S; Abdul-Hamid H; Abd-Majid F; Abu-Bakar N; Nawawi H; Yusoff K
    Biomed Res Int; 2013; 2013():760963. PubMed ID: 24175300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of four definitions of the metabolic syndrome in a Greek (Mediterranean) population.
    Athyros VG; Ganotakis ES; Tziomalos K; Papageorgiou AA; Anagnostis P; Griva T; Kargiotis K; Mitsiou EK; Karagiannis A; Mikhailidis DP
    Curr Med Res Opin; 2010 Mar; 26(3):713-9. PubMed ID: 20078335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of metabolic syndrome prevalence using four different definitions - a population-based study in Finland.
    Haverinen E; Paalanen L; Palmieri L; Padron-Monedero A; Noguer-Zambrano I; Sarmiento Suárez R; Tolonen H;
    Arch Public Health; 2021 Dec; 79(1):231. PubMed ID: 34949223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of Metabolic Syndrome among Malaysians using the International Diabetes Federation, National Cholesterol Education Program and Modified World Health Organization Definitions.
    Bee YT; Haresh KK; Rajibans S
    Malays J Nutr; 2008 Mar; 14(1):65-77. PubMed ID: 22691765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of vascular disease in metabolic syndrome using three proposed definitions.
    Athyros VG; Ganotakis ES; Elisaf MS; Liberopoulos EN; Goudevenos IA; Karagiannis A;
    Int J Cardiol; 2007 Apr; 117(2):204-10. PubMed ID: 16854482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of metabolic syndrome in Nepalese type 2 diabetic patients according to WHO, NCEP ATP III, IDF and Harmonized criteria.
    Pokharel DR; Khadka D; Sigdel M; Yadav NK; Acharya S; Kafle RC; Shukla PS
    J Diabetes Metab Disord; 2014; 13(1):104. PubMed ID: 25469328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The reliability of the National Cholesterol Education Program's Adult Treatment Panel III (NCEP/ATP III) and the International Diabetes Federation (IDF) definitions in diagnosing metabolic syndrome (MetS) among Gaza Strip Palestinians.
    Sirdah MM; Abu Ghali AS; Al Laham NA
    Diabetes Metab Syndr; 2012; 6(1):4-8. PubMed ID: 23014247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparisons of different metabolic syndrome definitions and associations with coronary heart disease, stroke, and peripheral arterial disease in a rural Chinese population.
    Wen J; Yang J; Shi Y; Liang Y; Wang F; Duan X; Lu X; Tao Q; Lu X; Tian Y; Wang N
    PLoS One; 2015; 10(5):e0126832. PubMed ID: 25961739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of metabolic syndrome in elderly and agreement among four diagnostic criteria.
    Saad MA; Cardoso GP; Martins Wde A; Velarde LG; Cruz Filho RA
    Arq Bras Cardiol; 2014 Mar; 102(3):263-9. PubMed ID: 24676226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing the association of two metabolic syndrome definitions, NCEP ATP III and IDF, with the risk of developing atherosclerotic cardiovascular disease: An analytical cross-sectional study.
    Yousefzadeh G; Sayyadi A; Najafipour H; Sabaghnejad V; Pezeshki S
    Endocrinol Diabetes Metab; 2024 Jan; 7(1):e468. PubMed ID: 38268305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Three Diagnostic Definitions of Metabolic Syndrome and Estimation of Its Prevalence in Mongolia.
    Myagmar-Ochir E; Haruyama Y; Takaoka N; Takahashi K; Dashdorj N; Dashtseren M; Kobashi G
    Int J Environ Res Public Health; 2023 Mar; 20(6):. PubMed ID: 36981866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Comparison of the Prevalence of the Metabolic Syndrome among Sri Lankan Patients with Type 2 Diabetes Mellitus Using WHO, NCEP-ATP III, and IDF Definitions.
    Herath HMM; Weerasinghe NP; Weerarathna TP; Amarathunga A
    Int J Chronic Dis; 2018; 2018():7813537. PubMed ID: 30175110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular risk and prevalence of metabolic syndrome by differing criteria.
    Li WJ; Xue H; Sun K; Song XD; Wang YB; Zhen YS; Han YF; Hui RT
    Chin Med J (Engl); 2008 Aug; 121(16):1532-6. PubMed ID: 18985935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and determinants of metabolic syndrome among adults in a rural area of Northwest China.
    Zhao Y; Yan H; Yang R; Li Q; Dang S; Wang Y
    PLoS One; 2014; 9(3):e91578. PubMed ID: 24614618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of Metabolic Syndrome and its Associated Factors among Multi-ethnic Adults in Rural Areas in Xinjiang, China.
    Guo H; Gao X; Ma R; Liu J; Ding Y; Zhang M; Zhang J; Mu L; He J; Yan Y; Ma J; Guo S; Wei S
    Sci Rep; 2017 Dec; 7(1):17643. PubMed ID: 29247195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of undiagnosed metabolic syndrome using three different definitions and identifying associated risk factors among apparently healthy adults in Karachi, Pakistan: a cross-sectional survey in the year 2022.
    Adil SO; Musa KI; Uddin F; Khan A; Khan I; Shakeel A; Shafique K; Islam MA
    Arch Public Health; 2024 Feb; 82(1):22. PubMed ID: 38378657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A nationwide study of metabolic syndrome prevalence in Iran; a comparative analysis of six definitions.
    Tabatabaei-Malazy O; Saeedi Moghaddam S; Rezaei N; Sheidaei A; Hajipour MJ; Mahmoudi N; Mahmoudi Z; Dilmaghani-Marand A; Rezaee K; Sabooni M; Razi F; Kompani F; Delavari A; Larijani B; Farzadfar F
    PLoS One; 2021; 16(3):e0241926. PubMed ID: 33657130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with metabolic syndrome in a sample of women in Puerto Rico.
    Romaguera J; Ortiz AP; Roca FJ; Colón G; Suárez E
    Menopause; 2010 Mar; 17(2):388-92. PubMed ID: 19884863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of metabolic syndrome in type 2 diabetes mellitus using NCEP-ATPIII, IDF and WHO definition and its agreement in Gwalior Chambal region of Central India.
    Yadav D; Mahajan S; Subramanian SK; Bisen PS; Chung CH; Prasad GB
    Glob J Health Sci; 2013 Sep; 5(6):142-55. PubMed ID: 24171882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and correlates of metabolic syndrome among adults in freetown, Sierra Leone: A comparative analysis of NCEP ATP III, IDF and harmonized ATP III criteria.
    Russell JBW; Koroma TR; Sesay S; Samura SK; Lakoh S; Bockarie A; Abiri OA; Conteh V; Conteh S; Smith M; Mahdi OZ; Lisk DR
    Int J Cardiol Cardiovasc Risk Prev; 2024 Mar; 20():200236. PubMed ID: 38299125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.